BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7856280)

  • 1. [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Z Kardiol; 1994; 83 Suppl 4():53-6. PubMed ID: 7856280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
    Schölkens BA; Linz W
    Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
    Linz W; Wiemer G; Schölkens BA
    Braz J Med Biol Res; 1994 Aug; 27(8):1949-54. PubMed ID: 7749386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
    Linz W; Gohlke P; Unger T; Schölkens BA
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of bradykinin to the cardiovascular effects of ramipril.
    Linz W; Wiemer G; Schölkens BA
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S1-8. PubMed ID: 7514234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
    Schölkens BA; Linz W
    Clin Physiol Biochem; 1990; 8 Suppl 1():33-43. PubMed ID: 2147878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.
    Linz W; Itter G; Dobrucki LW; Malinski T; Wiemer G
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):180-5. PubMed ID: 14608524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
    Linz W; Lau HH; Beck G; Schökens BA
    Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramipril-induced delayed myocardial protection against free radical injury involves bradykinin B2 receptor-NO pathway and protein synthesis.
    Jin ZQ; Chen X
    Br J Pharmacol; 1998 Oct; 125(3):556-62. PubMed ID: 9806340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
    Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
    Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W; Wiemer G; Schölkens BA
    J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin-mediated metabolic effects in isolated perfused rat hearts.
    Schoelkens BA; Linz W
    Agents Actions Suppl; 1992; 38 ( Pt 2)():36-42. PubMed ID: 1462841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxide.
    Yang BC; Chen LY; Saldeen TG; Mehta JL
    Br J Pharmacol; 1997 Jan; 120(2):305-11. PubMed ID: 9117124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
    Freise H; Palmes D; Spiegel HU
    J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.